Positive Outcome After Intentional Overdose of Dabigatran
Positive Outcome After Intentional Overdose of Dabigatran
About this item
Full title
Author / Creator
Publisher
New York: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Introduction
Dabigatran (Pradaxa™), an orally active direct thrombin inhibitor, was approved by the United States Food and Drug Administration for the prevention of stroke in patients with atrial fibrillation in October 2010. Life-threatening consequences from dabigatran therapy include hemorrhage and bleeding complications, but they typically o...
Alternative Titles
Full title
Positive Outcome After Intentional Overdose of Dabigatran
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3657022
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3657022
Other Identifiers
ISSN
1556-9039
E-ISSN
1937-6995
DOI
10.1007/s13181-012-0276-5
